Pharmaceutical giant Roche has tapped University of Wisconsin researcher James Thomson to use heart cells derived from human embryonic stem cells to test new compounds that affect the human heart.
Office of Strategic Communication
Pharmaceutical giant Roche has tapped University of Wisconsin researcher James Thomson to use heart cells derived from human embryonic stem cells to test new compounds that affect the human heart.